Daniel is VP of R&D at Constructive Bio. After completing his BSc in Biotechnology at University College London, he obtained his PhD at Prof. Chin’s lab at the MRC Laboratory of Molecular Biology, where he developed foundational technologies for genome synthesis, being part of a core team that created Syn61, a synthetic strain of E. Coli that uses 61 codons, as opposed to 64, to make its proteins. In subsequent postdoctoral work in the Chin lab, Daniel reprogrammed the genetic code of Syn61 to enable the production of proteins containing 3 different non-natural amino acids. Daniel currently leads platform research at Constructive Bio, looking to reprogram the genetic code of living cells for the sustainable, genetically-encoded bioproduction of valuable biomolecules.

‍